RMD vs SYK: fair value comparison
ResMed Inc. and Stryker Corporation · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, SYK currently sits closer to the top of our discount ranking. RMD carries the stronger momentum grade.
| RMD | SYK | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $240.33 | $330.69 |
| 12-month range | $186.44–$270.99 | $294.73–$389.94 |
| Sector rank | #27 of 113 Healthcare | #24 of 113 Healthcare |
| Quality grade | A | A |
| Momentum grade | A | C |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: RMD fair value analysis · SYK fair value analysis